DrugPatentWatch Database Preview
Remimazolam besylate - Generic Drug Details
» See Plans and Pricing
What are the generic sources for remimazolam besylate and what is the scope of patent protection?
Remimazolam besylate
is the generic ingredient in one branded drug marketed by Acacia and is included in one NDA. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.Remimazolam besylate has fifty-three patent family members in twenty-four countries.
Summary for remimazolam besylate
International Patents: | 53 |
US Patents: | 10 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Bulk Api Vendors: | 14 |
Patent Applications: | 8 |
What excipients (inactive ingredients) are in remimazolam besylate? | remimazolam besylate excipients list |
DailyMed Link: | remimazolam besylate at DailyMed |
US Patents and Regulatory Information for remimazolam besylate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acacia | BYFAVO | remimazolam besylate | POWDER;INTRAVENOUS | 212295-001 | Oct 6, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Acacia | BYFAVO | remimazolam besylate | POWDER;INTRAVENOUS | 212295-001 | Oct 6, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Acacia | BYFAVO | remimazolam besylate | POWDER;INTRAVENOUS | 212295-001 | Oct 6, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
Acacia | BYFAVO | remimazolam besylate | POWDER;INTRAVENOUS | 212295-001 | Oct 6, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Acacia | BYFAVO | remimazolam besylate | POWDER;INTRAVENOUS | 212295-001 | Oct 6, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Acacia | BYFAVO | remimazolam besylate | POWDER;INTRAVENOUS | 212295-001 | Oct 6, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for remimazolam besylate
Country | Patent Number | Estimated Expiration |
---|---|---|
United Kingdom | 0613694 | Start Trial |
World Intellectual Property Organization (WIPO) | 2008007071 | Start Trial |
Portugal | 2637662 | Start Trial |
China | 104059071 | Start Trial |
South Korea | 20150081370 | Start Trial |
Canada | 2657347 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |